Here are the top 10 penny stocks of 2020
It’s a brand new year and that means a brand new set of powerful opportunities in the penny stocks space. Today, we’re going to take a quick look at ten of the most promising penny plays out there as we help you get prepared to capitalize in 2020!
Smart Decision Inc. (OTCMKTS:SDEC)
Smart Decision is an interesting algorithmic solution for new adopters entering the CBD space as consumers. It’s not easy to make sense of all the different variables as a first-time or inexperienced consumer of CBD products. You have to make sense of variables like potency, volume, grade, delivery mechanism, bioavailability, and other factors.
Smart Decision is developing an algorithmic tool to help new CBD users make the right decision right away. And it works as an affiliate marketing platform as well. That means the company will be benefitting consumers and producers by connecting them for transactions – and, naturally, taking its own piece of the action. The stock has already been red hot this year, and that may well continue.
Medmen Enterprises Inc (OTCMKTS:MMNFF)
Medmen, together with its subsidiaries, operates in the cannabis space in the United States. The stock took a freaky bad beating in 2019, and now has precisely 0% interest from speculative money. That presents an opportunity in 2020 if the cannabis space regains some traction.
MMNFF, more broadly, is a leading cannabis company in the U.S. with assets and operations across the country. Based in Los Angeles, MedMen brings expertise and capital to the cannabis industry and is one of the nation’s largest financial supporters of progressive marijuana laws.
The company cultivates, produces, possesses, uses, and distributes/retails cannabis in the recreational and medicinal cannabis marketplace. As of June 6, 2018, it owned and operated 18 licensed cannabis facilities under the MedMen brand name in California, Nevada, and New York.
Nextech Ar Solutions Corp (OTCMKTS:NEXCF)
Nextech bills itself as a company that engages in the acquisition and development of augmented reality (AR) technology. The stock has been hot and could get much hotter as its technology solution takes flight.
The company offers ARitize eCommerce, the browser-based and Web enabled AR shopping platform; ARitize Retail Showroom that provides choice, convenience, ratings, and reviews with the benefits of being in-store; ARitize App that allows to sell, learn, communicate, and share product, service, or experience through AR; and ARitize University, an AR learning system.
It also provides ARitize Studios, which enables customers to beam in to 3D volumetric space as a hologram, and create an interactive yet intimate connection with audiences from all over the world; and Hoot 3D eCommerce solution that shows 3D and 360 degree product photography.
Planet 13 Holdings Inc (OTCMKTS:PLNHF)
Planet 13 promulgates itself as a cannabis company that cultivates, produces, and distributes medical and recreational cannabis in Nevada, the United States.
It also operates dispensaries that provide recreational cannabis, cannabis extracts, and infused products. In addition, the company sells its products online. It operates under the Medizin and Planet 13 brand names. The company is headquartered in Las Vegas, Nevada.
As a vertically-integrated and established cannabis company in the Nevada market, Planet 13 Holdings, Inc. provides an array of cannabis products available through its licensed operations. Planet 13 Holdings, Inc. is focused on providing a dispensary experience and managing cultivation efficiencies through its technology. Planet 13 may be able to build on its position in the Nevada cannabis market as it seeks to expand its existing operations. In the Fall of 2018, the company was working to open a retail dispensary immediately adjacent to the Las Vegas strip.
CV Sciences Inc (OTCMKTS:CVSI)
CV Sciences bills itself as a company that operates two distinct business segments: a drug development division focused on developing and commercializing novel therapeutics utilizing synthetic CBD; and, a consumer product division focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors.
The stock was the singular breakout market leader in the CBD space in 2018 until it got chopped down, first by Citron’s Andrew Left in a series of bearish tweets, and second by the cannabis and CBD bear market that dominated 2019. Now, with a fresh hold of the dollar level, the possibility of a recovery year beckons in 2020.
Green Growth Brands Inc (OTCMKTS:GGBXF)
Green Growth trumpets itself as a company that engages in the cultivation, processing, production, distribution, and retailing of cannabis and cannabis-infused products in the United States.
The company offers cannabis, tetrahydro cannabidol, cannabidiol, and cannabis-infused consumer products, as well as technology and consulting services for the cannabis industry. Xanthic Biopharma Inc. was founded in 1968 and is headquartered in Toronto, Canada.
The Company is a lifestyle oriented, consumer products company that celebrates health, wellness and happiness. We are in the business of cultivation, processing and retailing of cannabis, tetrahydrocannabidol, cannabidiol and cannabis-infused consumer products.
Progressive Care Inc (OTCMKTS:RXMD)
Progressive Care has been putting up huge growth data in recent months, vaulting onto our radar as one of the most interesting penny plays out there. As it stands, this stock is likely not going to be on the OTC much longer, with an S-1 due in early Q2 along with an application to uplist onto the Nasdaq or NYSE.
The company operates a retail pharmacy that specializes in the sale of anti-retroviral medications and related patient care management; the sale and rental of durable medical equipment (DME), such as hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and other related equipment and accessories; and the supply of various prescription medications to long term care facilities.
It also provides long term care solutions to skilled nursing facilities, assisted living facilities, retirement centers and communities, doctors’ offices, and clinics. In addition, the company purchases, repackages, and dispenses prescription and non-prescription pharmaceutical products for its long term care customers.
Further, it offers computerized maintenance of patient prescription histories, third party billing, and consultant pharmacist services consisting of evaluation of monthly patient drug therapy and monitoring the institution’s drug distribution system, as well as home service and maintenance, defective product replacements, and free home installation and instruction services.
Surge Holdings Inc. (OTCMKTS:SURG)
Surge is a retail supply chain company that provides a virtual wholesale marketplace hub for retailers, as well as telecom services for low income customers and financial payment services for the unbanked and underbanked.
Surge products are delivered through a nationwide network of convenience stores and corner markets connected to the recently launched SurgePays Network.
This retail platform is designed to transform the traditional supply chain by providing local retailers seamless access to global products and to empower the corner store to select, order and fulfill delivery of wholesale goods from around the country.
This platform also provides manufacturers a cost-effective and efficient platform to access point of sale retailers nationwide.
Pharmacyte Biotech Inc (OTCMKTS:PMCB)
Pharmacyte trumpets itself as a clinical stage biotechnology company that focuses on developing and commercializing cellular therapies for cancer and diabetes in the United States.
Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable non-metastatic pancreatic cancer, as well as diabetes.
The company is developing therapies for pancreatic and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the activation of cancer-killing drugs to the source of the cancer. It is also developing a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes; and therapies for cancer based on the constituents of the cannabis plant.
Emerald Health Therapeutics Inc (OTCMKTS:EMHTF)
Emerald trumpets itself as a licensed producer of medical marijuana under the Access to Cannabis for Medical Purposes Regulations, which allows the company to produce and sell medical marijuana and cannabis oils to clients and other licensed producers.
Individuals may become clients of the company by registering with the company through its secure online portal or via telephone after the individual has received a medical document signed by a licensed health care practitioner setting out the daily quantity of dried marijuana, in grams, that the practitioner authorized for the person.
A Great Year Ahead for Penny Stocks?
There are a number of reasons to believe 2020 will represent a truly powerful year for investors and traders interested in the exciting penny stock space. Penny stocks offer dramatic potential because they can simply move more over any given period of time. 2019 represented a year of big drawdowns for cannabis, CBD, blockchain, and other thematic market spaces that contain a number of penny stock names. But 2020 may well end up showing us the other side of that coin, and generating huge returns for the skilled and nimble in the process.